Clinical data | |
---|---|
AHFS/ Drugs.com | International Drug Names |
Routes of administration | Inhalation ( MDI), IV |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.053.579 |
Chemical and physical data | |
Formula | C18H23N5O5 |
Molar mass | 389.412 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Reproterol is a short-acting [1] β2 adrenoreceptor agonist used in the treatment of asthma. [2]
It was patented in 1965 and came into medical use in 1977. [3]
Reproterol contains a stereocenter and is chiral. There are thus two enantiomers, the (R)-form and the (S)-form. The commercial preparations contain the drug as a racemate, an equal mixture of the two enantiomers. [4]
Enantiomers of reproterol | |
---|---|
(R)-Reproterol CAS number: 210710-33-1 |
(S)-Reproterol CAS number: 210710-34-2 |
Clinical data | |
---|---|
AHFS/ Drugs.com | International Drug Names |
Routes of administration | Inhalation ( MDI), IV |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.053.579 |
Chemical and physical data | |
Formula | C18H23N5O5 |
Molar mass | 389.412 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Reproterol is a short-acting [1] β2 adrenoreceptor agonist used in the treatment of asthma. [2]
It was patented in 1965 and came into medical use in 1977. [3]
Reproterol contains a stereocenter and is chiral. There are thus two enantiomers, the (R)-form and the (S)-form. The commercial preparations contain the drug as a racemate, an equal mixture of the two enantiomers. [4]
Enantiomers of reproterol | |
---|---|
(R)-Reproterol CAS number: 210710-33-1 |
(S)-Reproterol CAS number: 210710-34-2 |